Pinpointed Taste Receptor Stem Cells Could Help Treat Sense Loss
Taste receptor cells have a quick turnover rate. Every 10-16 days, new cells replace the old; yet, pinpointing the replenishing stem cell source has eluded researchers....
Taste receptor cells have a quick turnover rate. Every 10-16 days, new cells replace the old; yet, pinpointing the replenishing stem cell source has eluded researchers....
Brown fat, commonly thought as long-term energy source for hibernating animals, also plays an important role in blood sugar regulation and day-to-day metabolism. Previous studies have...
Please review all 17 applications in advance of the meeting, and come prepared to serve as the primary and secondary reviewer for the applications specifically assigned...
A new 3D printer technology deposits human embryonic stem cells in droplets. Building on 3D printer technology, this new platform can eject these fragile cells, which...
Radiation exposure often triggers cell death in hematopoetic, or blood-forming, stem cells. A study in Nature Medicine shows that the addition of a hormone following exposure could...
A team led by Heather Young and John Furness has demonstrated a possible cell therapy to treat gastrointestinal motility disorders like Hirschsprung disease. For patients with...
Under the cover of a mesenchymal stem cell, the tuberculosis (TB) bacterium persists, even years after living asymptomatically. A new study in Science Translational Medicine provides...
Arrhythmogenic right ventricular dysplasia/cadiomyopathy is a rare, inherited, and currently untreatable condition, which is a common cause of sudden death in adolescents. Researchers led by Daniel...
Approximately 20% of patients diagnosed with dry age-related macular degeneration develop the wet form, which leads to irreversible eye damage and eventual blindness. While the dry...
Rats, immediately following an induced ischemic stroke, fared better when injected with allogenic mesenchymal stem cells than a placebo. While there was no evidence of stem...
Japanese researchers led by Kenji Osafune report the successful generation of mesoderm kidney tissue from induced pluripotent stem cells. This particular tissue type—between a stem and...
Paola Arlotta, a NYSCF – Robertson Stem Cell Investigator, has reported in Nature Cell Biology the possibility to reprogram one type of neuron into another in...
NYSCF Investigator Ed Boyden’s pioneering work in the field of optogenetics is profiled in the Wall Street Journal. By genetically engineering mice, Boyden and his colleagues...
Genetic Engineering & Biotechnology News has named a recent breakthrough from the NYSCF Laboratory to its list of "10 Predictions That Will Transform Healthcare." This list captures...
Often, leukemia lays dormant before re-emerging. Researchers believe that a resistive subpopulation of leukemia stem cells underlie our current difficulty in eradicating this blood cancer....
It’s not just humans who can reprogram cells. The leprosy bacterium can infect and thereafter revert adult Schwann cells into stem-like cells. The infection is spread...
Children born with spinal muscular atrophy (SMA) have a grim prognosis: most infants rarely see it to their second birthday. This debilitating, genetic disease has no...
Reported in Science and Translational Medicine, a light-activated hydrogel helps to repair damaged cartilage by acting as a scaffold for stem cells. Jennifer Elisseeff and collaborators...
Duchenne muscular dystrophy (DMD), a rare genetic disorder, leads to muscle death and the formation of scar tissue due to a mutant copy of the dystrophin...
Project REBORNE will commence clinical trials to help repair fractured bone in France. Following successful pre-clinical work and approval by the French Medicinal Agency, autologous mesenchymal...
Hearing loss in mammals is thought irreversible: damage wrought to ear hair cells can lead to permanent deafness. A new study in Neuron from Albert Edge...
The results of a Nature study may quell long-held concerns over the safety of transplanted induced pluripotent stem (iPS) cells. In a 2011 investigation, transplanted...
A meta-analysis of 11 studies reveals that undifferentiated, mulitpotent neural stem cells (NSC) from mice or humans may slow the onset and mitigate the symptoms of...
During the 2013 Biotech Showcase in San Francisco, NYSCF CEO Susan L. Solomon presented on NYSCF’s role in the future of stem cell research at the...
The Supreme Court refused to hear an appeal from the plaintiff’s of Sherley v. Sebelius. Significantly, this marks the end of a years-long legal battle to...